- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Bridging the affordability gap | ||
| Fr | Vandria announces positive phase 1 data for Alzheimer's treatment | ||
| Fr | NRG Therapeutics appoints Paul Thompson as Chief Development Officer | ||
| Do | Roche receives FDA clearance for whooping cough test | ||
| Do | TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board | ||
| Do | Why bad habits are sabotaging your strategic decisions | ||
| Mi | Richard Pazdur, FDA's drug evaluation chief, to leave FDA just weeks into new role | ||
| Mi | Circle Pharma appoints Anne Borgman as Chief Medical Officer | ||
| Di | UK and US agree on landmark pharma pricing tariff deal | ||
| Di | Danish diabetes-tech company Hedia appoints Rasmus Kofoed as CEO | ||
| Mo | Eisai submits new drug application for subcutaneous Leqembi in Japan | ||
| Mo | AstraZeneca's Imfinzi receives FDA approval for gastric and gastro-oesophageal cancers | ||
| 28.11. | Novartis' Itvisma gets FDA approval for spinal muscular atrophy treatment | ||
| 28.11. | Regeneron's Libtayo receives EC approval for skin cancer | ||
| 28.11. | ESMO 2025 - ensuring innovation isn't lost in translation | ||
| 27.11. | Sandoz launches first and only multiple sclerosis biosimilar in US | ||
| 27.11. | Tonix launches new oral fibromyalgia treatment | ||
| 27.11. | Agility in medical affairs: responding to rapid market and regulatory shifts | ||
| 27.11. | Optimised therapy to improve outcomes for heart attack and stroke patients | ||
| 27.11. | The new era of medical affairs: busting myths and supercharging strategic value | ||
| 26.11. | J&J's Tremfya improves symptoms of psoriatic arthritis including joint damage | ||
| 26.11. | Novartis announces plans for new US manufacturing hub | ||
| 25.11. | The most overlooked KPI in business? Joy | ||
| 25.11. | Reimagining pharma CX: three game-changing products driving human-centric innovation | ||
| 25.11. | When populism meets public health: trust under siege |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .